Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy?

Weight gain following the initiation or the switch of antiretroviral therapy (ART) is well documented and mainly associated with some of the most recent drugs, such as integrase strand transfer inhibitors and tenofovir alafenamide. However, limited data have been published on weight trends in ART-experienced people living with HIV (PLWH) with a long exposure to HIV infection and antiretroviral drugs. In our study, we assessed changes in weight after switching ART among PLWH who reported weight gain under a previous regimen.

Citation

Camilla Muccini, Daniele Ceccarelli, Riccardo Lolatto, Vincenzo Spagnuolo, Chiara Oltolini, Anna Danise, Ilaria Mainardi, Roberta Monardo, Antonella Castagna. Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy? The new microbiologica. 2023 Feb;46(1):65-67

Mesh Tags

Substances

PMID: 36853821

search → result